Drug shortages
-
Caught my eye — 2/16/24
Read more: Caught my eye — 2/16/24Honestly? Not a lot caught my eye this week. Maybe we were all heads down getting stuff done before a long weekend? You say MPPP, I say smoothing. Late yesterday afternoon the Centers for Medicare & Medicaid Services released Draft 2 guidance for the Medicare Prescription Payment Plan. I’ve heard Michael Ward from Alliance for…
-
340B, Alzheimer’s, Caught my eye, Drug Prices, Drug shortages, Medicare Advantage, State-based ReformCaught my eye — 1/26/24
Read more: Caught my eye — 1/26/24It has been fun to see the year really start to kick off this week with a bunch of policy releases. Shortages. Generic shortages are caused by a myriad of factors, but a big piece is the race to the bottom for prices. A fraction of a penny less and a contract shifts to another…
-
Caught my eye — 12/1/23
Read more: Caught my eye — 12/1/23Patient no more. A few weeks ago I wrote about how thanks to the HIV Hepatitis Policy Institute, the Diabetes Leadership Council and the Diabetes Patient Advocacy Coalition and their suit against the Department of Health and Human Services, accumulator programs were dealt a blow. They can only be used if it is for a branded…
-
Caught my eye — 10/27/23
Read more: Caught my eye — 10/27/23Caught my ear? This story on NPR about drug shortages and how one woman is trying to plug the holes was fantastic. Two takeaways – (1) never underestimate a mother whose kid needs help and (2) figuring out drug shortages should be more systematic and not a game of “whack a mole.” Nothing but net.…
Latest news
- AMP is WAC — 03/13/26
- AMP is WAC — 3/6/26
- AMP is WAC — 02/27/26
- AMP is WAC — 2/20/26
- AMP is WAC — 2/13/26
Categories
- 340B (63)
- Affordable Care Act (22)
- Alzheimer's (11)
- Biosimilars (32)
- Caught my eye (101)
- Cell and Gene (6)
- Chevron Deference (2)
- CMMI (27)
- Copay Accumulators (7)
- COVID (3)
- Drug Prices (55)
- Drug shortages (14)
- DTC (6)
- Employers (20)
- FDA (7)
- Generics (12)
- Health Equity (4)
- Healthcare Costs (39)
- Home Health (1)
- ICER (12)
- Importation (5)
- Inflation Reduction Act (68)
- Insulin (7)
- IP (3)
- Long term care (1)
- Medicaid (22)
- Medicare Advantage (27)
- Medicare Negotiation (68)
- Medicare Part D (77)
- Medicare Transaction Facilitator (5)
- Medicare Transaction Facilitator (12)
- Obesity (27)
- On the Horizon (1)
- Orphan Drugs (8)
- Pharmacy Benefit Managers (48)
- Preventative (5)
- Reference Pricing (26)
- State-based Reform (30)
- Supply Chain (7)
- Tariffs (1)
- Uncategorized (8)
- Utilization Management (11)
- Vaccines (9)
- Value (18)